(Q38035344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Recent advances targeting innate immunity-mediated therapies against HIV-1 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

Ramachandran Vignesh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Esaki Muthu Shankar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sivakumar Vijayaraghavalu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Devi Velayuthan Rukumani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Negar Shafiei Sabet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

Microbiology and Immunology

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

497-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22900503%20AND%20SRC:MED&resulttype=core&format=json

Targeting HIV-1 innate immune responses therapeutically

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Recognition of microorganisms and activation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Mucosal innate immunity as a determinant of HIV susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Chemokines and defensins as HIV suppressive factors: an evolving story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Persistence of gut mucosal innate immune defenses by enteric α-defensin expression in the simian immunodeficiency virus model of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Retrocyclins and their activity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Reawakening retrocyclins: ancestral human defensins active against HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Retrocyclin, an Antiretroviral θ-Defensin, Is a Lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Interferon-λ in HCV Infection and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Morphine suppresses IFN signaling pathway and enhances AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Anti-human immunodeficiency virus noncytolytic CD8+ T-cell response: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Inhibition of HIV-1 infection by the beta-chemokine MDC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Cytokines and HIV-1: interactions and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Plasmacytoid dendritic cells reduce HIV production in elite controllers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Chronic innate immune activation as a cause of HIV-1 immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV-1 immunopathogenesis: how good interferon turns bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Tryptophan catabolism and regulation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Nef proteins from simian immunodeficiency viruses are tetherin antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

θ-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X

HIV Interplay with SAMHD1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2012.00485.X